NCT02544165View on ClinicalTrials.gov

Non Invasive Measurement of the Haemodynamic Parameters and of the Advanced Glycation End Products (AGEs) Levels

NACompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

June 30, 2014

Conditions
Hemodynamic InstabilitySkin and Subcutaneous Tissue Disorders
Interventions
DIETARY_SUPPLEMENT

caffeine intake

The subjects of this group should intake 100 mg of caffeine after the first measurement of haemodynamic parameters with the Finometer device and after the first measurement of the advanced glycation end products accumulation with AgeReader device.

OTHER

cigarette smoking

The subjects of this group should smoke one cigarette after the first measurement of haemodynamic parameters with the Finometer device and after the first measurement of the advanced glycation end products accumulation with AgeReader device.

OTHER

Caffeine intake and Cigarette smoking

The subjects of this group should smoke one cigarette and should consume 100 mg of caffeine after the first measurement of haemodynamic parameters with the Finometer device and after the first measurement of the advanced glycation end products accumulation with AgeReader device.

Trial Locations (1)

35100

Technological Educational Institute of Sterea Ellada, Lamia

All Listed Sponsors
collaborator

European Union

OTHER

lead

Technological Education Institute of Sterea Ellada

OTHER

NCT02544165 - Non Invasive Measurement of the Haemodynamic Parameters and of the Advanced Glycation End Products (AGEs) Levels | Biotech Hunter | Biotech Hunter